New heart health guidelines start as early as age 30: What you need to know

Written by Leslie Saltzman, DO, Vice President of Consumer Health Solutions and Medical Discipline Director, Labcorp 

For decades, most conversations about cholesterol and heart disease prevention began in midlife, often around age 40 or later. New cardiovascular prevention guidelines are changing that narrative in an important way. The 2026 American College of Cardiology/American Heart Association Guideline on the Management of Dyslipidemia now recommends that adults as young as 30 consider earlier evaluation and action to manage cholesterol and long-term heart health risk. That includes understanding cholesterol levels, assessing long-term cardiovascular risk, and taking steps such as testing, lifestyle changes, and, when appropriate, medication to help protect heart health earlier in life.

This shift reflects a sobering reality: In the U.S., heart disease and stroke account for more than a quarter of all deaths, and growing evidence suggests that heart disease develops slowly over time, often beginning decades before symptoms appear. By identifying higher-risk individuals earlier, we gain more opportunities to prevent serious cardiovascular events later in life. 

What’s new in the cardiovascular guidelines and why it matters 

The updated recommendations are based on the PREVENT™ cardiovascular risk calculator introduced in 2023, which estimates both 10- and 30-year risk for adults aged 30-79. This longer-term view is particularly relevant for younger adults who may not appear “high-risk” today yet could face significant cardiovascular disease (CVD) over time. 

Under the new guidance, adults without known heart disease are encouraged to act if their risk is borderline or higher. Action begins with lifestyle changes and medications such as statins. 

Understanding cholesterol beyond a single number 

Cholesterol is nuanced. While low-density lipoprotein (LDL) cholesterol plays a central role in plaque buildup inside the arteries, it’s only one part of a larger picture for heart health. Other indicators, such as high-sensitivity C-reactive protein, lipoprotein(a) and apolipoprotein B (ApoB), can help provide a more complete view of cardiovascular risk. Under the new guidelines, these test results are meant to personalize one’s risk assessment.

This is why testing can be so valuable. Comprehensive blood testing allows individuals and their healthcare providers to understand baseline risk, track changes over time, and make more informed decisions about lifestyle modifications or medication. 

For those interested in proactive insight, options like Labcorp OnDemand’s Comprehensive Heart Health Test or the Complete Heart Health Test (with ApoB) can measure multiple indicators tied to cardiovascular risk. These tests can be especially helpful if you have a family history of heart disease or questions about how the new guidelines apply to you personally. 

Prevention starts with everyday choices and trusted guidance 

Whether you are 30 or 60, the foundation of heart health remains the same: getting balanced nutrition, engaging in regular physical activity, maintaining a healthy weight, managing stress, avoiding smoking, and prioritizing regular check-ups and screening. For some, these steps may be enough. For others, medications may be indicated to lower risk.  

The most important step is partnering with a healthcare provider who understands your personal and family health history. Together, you can decide which tests are appropriate, how to interpret results, and when lifestyle changes or medication may be beneficial. 

The takeaway from these new guidelines is empowering: heart disease prevention doesn’t have to wait. By understanding risk earlier and taking informed action, we can help protect heart health for decades to come.